HQL vs. SCHD
Compare and contrast key facts about Tekla Life Sciences Investors (HQL) and Schwab US Dividend Equity ETF (SCHD).
SCHD is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Dividend 100 Index. It was launched on Oct 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HQL or SCHD.
Correlation
The correlation between HQL and SCHD is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HQL vs. SCHD - Performance Comparison
Key characteristics
HQL:
0.90
SCHD:
1.19
HQL:
1.29
SCHD:
1.76
HQL:
1.17
SCHD:
1.21
HQL:
0.56
SCHD:
1.70
HQL:
3.04
SCHD:
4.36
HQL:
5.03%
SCHD:
3.10%
HQL:
17.03%
SCHD:
11.38%
HQL:
-61.70%
SCHD:
-33.37%
HQL:
-10.23%
SCHD:
-3.68%
Returns By Period
In the year-to-date period, HQL achieves a 8.77% return, which is significantly higher than SCHD's 3.15% return. Over the past 10 years, HQL has underperformed SCHD with an annualized return of 2.79%, while SCHD has yielded a comparatively higher 11.18% annualized return.
HQL
8.77%
3.71%
-2.52%
15.53%
5.34%
2.79%
SCHD
3.15%
0.68%
4.27%
13.92%
11.66%
11.18%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HQL vs. SCHD — Risk-Adjusted Performance Rank
HQL
SCHD
HQL vs. SCHD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HQL vs. SCHD - Dividend Comparison
HQL's dividend yield for the trailing twelve months is around 10.30%, more than SCHD's 3.53% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 10.30% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% | 7.11% |
SCHD Schwab US Dividend Equity ETF | 3.53% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% | 2.63% |
Drawdowns
HQL vs. SCHD - Drawdown Comparison
The maximum HQL drawdown since its inception was -61.70%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for HQL and SCHD. For additional features, visit the drawdowns tool.
Volatility
HQL vs. SCHD - Volatility Comparison
Tekla Life Sciences Investors (HQL) has a higher volatility of 4.28% compared to Schwab US Dividend Equity ETF (SCHD) at 3.23%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.